| 2024 |
Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis |
Articolo in rivista |
Vai |
| 2024 |
Unveiling Novel Hybrids Quinazoline/Phenylsulfonylfuroxan Derivatives with Potent Multi-Anticancer Inhibition: DFT and In Silico Approach Combining 2D-QSAR, Molecular Docking, Dynamics Simulations, and ADMET Properties |
Articolo in rivista |
Vai |
| 2024 |
INVESTIGATING THE NR2F2 STRUCTURE FOR DRUG REPURPOSING |
Abstract in atti di convegno pubblicato in volume |
Vai |
| 2024 |
Natural products as non-covalent and covalent modulators of the KEAP1/NRF2 pathway exerting antioxidant effects |
Articolo in rivista |
Vai |
| 2023 |
Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome |
Articolo in rivista |
Vai |
| 2023 |
Investigating the inhibition of FTSJ1 a tryptophan tRNA-specific
2’-O-methyltransferase by NV TRIDs, as a mechanism of readthrough in
nonsense mutated CFTR |
Articolo in rivista |
Vai |
| 2023 |
Non-covalent immunoproteasome inhibitors: virtual screening and in vitro test on β1i /β5i subunits |
Abstract in atti di convegno pubblicato in volume |
Vai |
| 2023 |
Exploring the new non-covalent immunoproteasome inhibitors of β1i /β5i subunits: Virtual screening and in vitro test |
Abstract in atti di convegno pubblicato in volume |
Vai |
| 2023 |
Aminoquinolines: Fluorescent sensors to DNA – A minor groove probe. Experimental and in silico studies |
Articolo in rivista |
Vai |
| 2023 |
Fighting Antibiotic Resistance: New Pyrimidine-Clubbed Benzimidazole Derivatives as Potential DHFR Inhibitors |
Articolo in rivista |
Vai |
| 2023 |
Treatment of Complex Regional Pain Syndrome (Crps): New Perspectives in the Use of Sulfonamides as Modulators of P2x Receptors |
Review essay (rassegna critica) |
Vai |
| 2022 |
In Silico Design, Synthesis and Biological Evaluation of Anticancer Arylsulfonamide Endowed with Anti-Telomerase Activity |
Articolo in rivista |
Vai |
| 2022 |
Sulfonamide moiety as "molecular chimera" in the design of new drugs |
Review essay (rassegna critica) |
Vai |
| 2021 |
Exploring the non-covalent ligand-binding mechanism on immunoproteasome by enhanced Molecular Dynamics |
Abstract in atti di convegno pubblicato in volume |
Vai |
| 2021 |
Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods |
Articolo in rivista |
Vai |
| 2021 |
Evaluation of the IKKβ Binding of Indicaxanthin by Induced-Fit Docking, Binding Pose Metadynamics, and Molecular Dynamics |
Articolo in rivista |
Vai |
| 2020 |
A definitive pharmacophore modelling study on CDK2 ATP pocket binders: Tracing the path of new virtual high-throughput screenings |
Articolo in rivista |
Vai |
| 2020 |
Exploring the SARS-CoV-2 proteome in the search of potential inhibitors via structure-based pharmacophore modeling/docking approach |
Articolo in rivista |
Vai |
| 2020 |
Pharmacophore-Based Design of New Chemical Scaffolds as Translational Readthrough-Inducing Drugs (TRIDs) |
Lettera |
Vai |
| 2020 |
Comparing molecular dynamics-derived pharmacophore models with docking: A study on CDK-2 inhibitors |
Articolo in rivista |
Vai |
| 2019 |
Indicaxanthin, a multi-target natural compound from Opuntia ficus-indica fruit: From its poly-pharmacological effects to biochemical mechanisms and molecular modelling studies |
Articolo in rivista |
Vai |
| 2019 |
Uno studio comparativo in silico sui possibili target di Ataluren e analoghi farmaci promotori di readthrough di codoni di stop prematuri |
Contributo in atti di convegno pubblicato in volume |
Vai |
| 2019 |
TOWARD ENRICHED VHTS FOR CDK2 INHIBITORS: MOLECULAR DYNAMICS, PHARMACOPHORE MODELLING, AND DOCKING |
Abstract in atti di convegno pubblicato in volume |
Vai |
